2
Registered trials
1
Recruiting
2
Unique sponsors
2
Unique IMPs
2
Commercial trials
Drug classes (ATC)
M
Musculoskeletal (ATC M)
1
N
Neurology/Psychiatry (ATC N)
1
—
ATC code not specified
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
2 substances
Phase III:
1
Phase II:
1
Phase III
1 trial-
EndedNovo Nordisk A/S CommercialSOMAPACITAN
Phase II
1 trial-
RecruitingBiomarin Pharmaceutical Inc. CommercialVOSORITIDE
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Biomarin Pharmaceutical Inc. | Commercial | 1 | Phase II | 1 |
| Novo Nordisk A/S | Commercial | 1 | Phase III | 0 |
New trials by year
2023
1
2025
1